Early research (Phase 1)Study completedNCT01558323What this trial is testingPharmacokinetics of LCQ908 in Patients With Renal ImpairmentWho this might be right forRenal Impairment Novartis Pharmaceuticals 58
Early research (Phase 1)Study completedNCT01594957What this trial is testingPharmacokinetics of LCQ908 in Patients With Hepatic ImpairmentWho this might be right forHepatic Impairment Novartis Pharmaceuticals 53
Early research (Phase 1)Study completedNCT00567047What this trial is testingPharmacokinetic Study of Vildagliptin in Patients With Renal ImpairmentWho this might be right forType-2 Diabetes Novartis 96
Not applicableStudy completedNCT02110875What this trial is testingStrength and Balance in Gender- and Age-Matched ControlsWho this might be right forHealthy Volunteers Oregon Health and Science University 25
Not applicableStudy completedNCT01379716What this trial is testingEvaluation of Five Selected Markers in Skin Biopsies of Patients With Postherpetic Neuralgia and Healthy ControlsWho this might be right forPostherpetic NeuralgiaHealthy Age/Gender Matched Volunteers Albany Medical College 10
Early research (Phase 1)Study completedNCT05515432What this trial is testingLearn How the Study Treatment BAY3283142 Taken as Single Dose by Mouth Moves Into, Through, and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Reduced Kidney Function Compared to Participants With Normal Kidney Function of Similar Age, Gender, and WeightWho this might be right forChronic Kidney DiseaseRenal ImpairmentHealthy Volunteers Bayer 45
Early research (Phase 1)Study completedNCT00572650What this trial is testingPharmacokinetic Study of LAF237 and Its Metabolites in Mild Renal Impaired PatientsWho this might be right forType 2 Diabetes Mellitus Novartis 29